Lung Cancer: Chaired by D. Ross Camidge, MD, PhD

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of oncology.

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of oncology.

Speakers

  • D. Ross Camidge, MD, PhD | University of Colorado
  • Rao Mushtaq, MD | National Jewish Hospital
  • Vignesh Narayanan, MD | Kaiser Permanente, Colorado

Topics

  • Frontline Treatment of NSCLC
  • Targetable Oncogene Updates in NSCLC - EGFR
  • Targetable Oncogene Updates - ALK/ROS1/Other- Testing Issues